chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was given a ZOSTAVAX injection on 9-3-08; presented to me today (9-10-08) with a slight red patch across the back of her arm, near where the shot was given. Stated itching and periodic pain at sight.
Pt presented to Emergency room on 25 November, approximately 15 days post primary vaccinia vaccination.  Seen by on-call provider, who consulted Interinst.  From provider note: no sexual contact for some time, no lesions on genitals, Pt had major rxn on R arm in scab stage, and 3 deep papules on L hand, 1 vessicle and 4 small papules.  On R hand, pt had 4 papules.  Provider suspected generalized vaccinia, spoke with doctor at HC.  HC recommended close monitoring, no indication for VIG at this time, pt instructed in contact precautions, sent home on quarters, given gloves to wear while sleeping and to wash face.  There was NO eye involvement.  Pt instructed to return to hospital with any further complications.
5 minutes following injection, left ear began to feel 'itchy/tingling' in middle ear location, moving to inside upper throat area then to right middle ear.  Approximately 2 minutes later, patient felt shortness of breath, mild chest pain and difficulty breathing.  She immediately took 25mg Benadryl PO.  20 minutes following injection, RN at site notified of symptoms.  HR 110, feeling flush, no change in other symptoms, patient escorted outside (15F weather) and  second dose of 25mg Benadryl PO given.  22 minutes following injection, remaining outside, improvement in ability to breathe.  HR 90.  Tingling/itchy feeling still in left middle ear, right middle ear improving.  24 minutes following injection, no further change in symptoms except HR 80.  45 minutes following injection, HR 70, dull headache beginning, throat feeling 'scratchy', but no difficulty breathing or chest pain at this time.  Patient is employee at site and remained under observation for one hour.  No further change in symptoms.
Information has been received from a registered nurse concerning a 86 year old patient who on 11-JUL-2007 was vaccinated with ProQuad (Enders-Edmonston, Jeryl Lynn, Wistar RA 27/3, Oka/Merck upgrade process) (lot # 6587536/0475U) instead of Zostavax (Oka/Merck).  On 24-AUG-2007 the patient was administered Zostavax (Oka/Merck) (lot # 656859/0357U).  Concomitant therapy included TOPROL XL TABLETS, losartan potassium (MSD), PERMIRAN, and "cloredine".  The site reported that this was not product confusion.  No adverse experience was related to this event.  No further information was available.  No product quality complaint was involved.  Additional information has been requested.  Follow-up information received from a registered nurse stated that they have been very busy and have someone pull the vaccines for them.  Normally the vaccines are checked twice but because it was so busy, it was not.  There was nothing further to report.  Additional information is not expected.
Slight rash at injection site, occurred about a week after the injection. It was approximately 3 inches x3 inches at the most, and was only slightly itchy. It went away on its own within 3-4 days, no treatment was needed. Also had a sore left arm for about 48 hours that resolved on its own of course.
Vaccine given 11-5-2015 11-6-2015 for 5 days had extreme fatigue, body aches, pain left deltoid (site of injection) which radiated to left shoulder and neck. Had intermittent twitching of muscles left arm. Several symptoms lasted 5 days. "Took a few more days to feel normal". No fever no cough.
Severe tinnitus (ringing) in both ears. Started 3 days after 2nd dose on April 27th. Constant; cannot sleep. Ears are clogged and popping.
I had a sensation of what I can describe as either a mild sunburn or chafing all over my body. My most sensitive areas were the back of my leg bottom of my feet and both arms. Sensitive to the touch and even wearing my clothes was uncomfortable. It started when I woke up around 6 am I went to work and was able to get to 11 o clock but on my break I got Benadryl and took it. I noticed my skin had a faint red undertone. 30 minutes after the Benadryl the symptoms all started to subside
Since receiving the vaccine I have experienced constant pain in the arm that the shot was given. This pain has spread into my armpit/chest area. I have lost strength and the ability to lift anything without severe pain in this arm.
Resident passed away 5 days after getting the booster dose. Received Primary Moderna vaccine on 8/20/2021 and 9/17/2021. Booster dose on 3/2/2022. Resident died on 3/7/2022.
After second dose I ended up in the hospital not even a month later. I was diagnosed with pericarditis and have had it for almost a year now. I?ve ended up in the hospital a total of three times and get extreme flare ups every month. Medication treatments are not working, everything fails. I have had no health issues my entire life and none recorded in family members. My life has completely changed because of it. I live in fear now and feel I?ll never be the same again. I regret getting the vaccine. I truly feel this will eventually kill me. CDC or Pfizer should cover all of my medical bills. This vaccine was supposed to save my life but instead it?s taking it away from me.
dizziness; This is a spontaneous report from a contactable consumer or other non hcp. An elderly male patient with unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown and expiry date: unknown), dose 2 via an unspecified route of administration on 24Mar2021 as dose 2, single for covid-19 immunisation. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown and expiry date: unknown), dose 1 via an unspecified route of administration on 03Mar2021 for single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced dizziness on 25Mar2021. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Narrative: Received 1st vaccine on 01/25/2021; sustained TIA on 01/28/2021. ER and discharged to home within 24 hours, recommendations to f/u with both neuro and cardiology. Moderna recommended that the patient not be given the 2nd dose.
This case was reported by a healthcare professional that described the occurrence of injection site burning in four to five subjects of unspecified ages and genders who were vaccinated with FLULAVAL (GlaxoSmithKline). On an unspecified date(s), the subjects received unspecified doses of FLULAVAL (unknown). At an unspecified time after vaccination with FLULAVAL, the subjects experienced injection site burning. An employee reported that four to five subjects experienced burning at the injection site following FLULAVAL vaccine. At the time of reporting, the outcome of the events were unspecified. No other information was known by the reporter, and no patient specific identifiers were provided.
burning up all day; pain in her hip and it went to her toes; pain in her hip and it went to her toes; Nausea; This is a spontaneous report from a non-contactable consumer (patient). A 90-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date (at the age of 90-year-old) as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced burning up all day, pain in her hip and it went to her toes (One night), nausea and by the time she got a bowl it was gone. The outcomes of events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a nurse practitioner who heard from an emergency room (ER) nurse that an 11 year old female was vaccinated "within in the past month" in approximately May 2007 with a first dose of Gardasil. Subsequently, 3 days after vaccination the patient presented to an ER. She experienced cardiac arrest, required lung bypass (ECMO) and "may not have expired." It was also reported by the same nurse that the physician from the hospital said that "the death was due to an anaphylactic reaction to Gardasil." The anaphylactic reaction and cardiac arrest were considered to be life threatening by the reporter. Additional information has been requested.
Immediately after the patients 2nd dose of her covid 19 Pfizer vaccine she began to feel "itchy" and had a palm size red area on her right shoulder. She also complained of and "itchy mouth". She was assessed by an RN and PA and given 50 mg of liquid Benadryl and monitored for 30 minutes.
Patient had ED visit and was admitted to hospital 39 days after receiving covid vaccine dose #2.
pt recv vax 21NOV94 & 24NOV94 devel involuntary twitching @ noc in sleep;mom noted that pt jerked around in sleep & @ times seemed like wasn't sleeping;devel a fever x 3d;29NOV94 presented to MD w/twitching @ noc, diff catching breath
pt brought to ED with c/o SOB and difficulty breathing; O2 sats 50% upon EMS arrival; intubated; placed on ventilator; HX:  COPD, HTN, hypokalemia, hypothyroidism; respiratory failure; pt's condition worsened and he died in the hospital
painful lymphadenopathy in right armpit for close to a week - most painful days 1-3.  Injection site stung bad during administration unlike first 2 doses - maybe that's related? Took motrin to help with pain but eventually went away on its own.
No additional information; Patient missed second dose of vaccine series for unspecified reason, will be receiving his second dose in the vaccine series late; This spontaneous report was received from a registered nurse and refers to an 8-year-old male (also reported gender: not applicable) patient. Patient's concurrent conditions, drug reactions or allergies, pertinent medical history and concomitant therapies were not reported.      On an unknown date the patient was vaccinated with a first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (dose, lot #, expiration date, albumin status and route were not reported) for prophylaxis.  On unknown date in approximately 2021 (reported asprior to starting school this year), the patient was receiving second dose of  measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (dose, lot #, expiration date, albumin status and route were not reported) for prophylaxis. The patient had missed the second scheduled dose years ago for unspecified reasons (inappropriate schedule of product administration).  The patient's family wanted to ensure that the child would not be putting at risk for shedding the virus to an immunocompromised family member after administration the vaccine. The family member was undergoing chemotherapy. No additional information was reported (no adverse event).
Hardness that was sensitive to touch; Pain at injection site/very sore in left arm; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE INDURATION (Hardness that was sensitive to touch) and VACCINATION SITE PAIN (Pain at injection site/very sore in left arm) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included DENOSUMAB (PROLIA) for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE INDURATION (Hardness that was sensitive to touch) and VACCINATION SITE PAIN (Pain at injection site/very sore in left arm). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, VACCINATION SITE INDURATION (Hardness that was sensitive to touch) and VACCINATION SITE PAIN (Pain at injection site/very sore in left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Veteran was found by family slumped over and unresponsive  at the breakfast table  on 1/13/21,  had expired
Started on day 5. Began day feeling extreme fatigue, dizziness, chest pain. Went to emergency room for chest pain. No indication of heart attack per ER. Extreme fatigue lasted for 3 days.
Patient stated on the phone on 9/30/22 that she was diagnosed as having SIRVA from her PCP and given steroids and ibuprofen. She stated that her right arm was very sore for 2 days, then it went away and then it came back very painful so she went to the Doctor.
On day 10, after receiving 1st dose of Moderna vaccine ,Rectal hemorrhage during the night and, Bloody stool,  Two weeks later, petechiae on stomach and blood on t shirt  upon arising.
MENVEO was injected SQ instead of IM Pt advised to contact Dr if painful and any other symptoms.
My right arm has not stopped hurting since I received the vaccine on 3.7.21. I cannot lift my arm or move it without it hurting. The strength in the right arm has also decreased. I have not injured or worked out my arm since I received the vaccine. I have tried to ice, heat, and move the arm gently, but nothing seems to lessen the pain and soreness. I have no injury history on my right arm or the right side of my upper body.
Unexplained dramatic drop in INR from 2.9 on January 11, 2021 to 1.3 on January 25, 2021. No symptoms experienced SQ Lovenox was initiated Follow-up INR is scheduled for January 27, 2021
Patient felt faint after the vaccine, had pre-syncopal episode. Laid on cot and made full recovery.
Psoriasis on chest: red blotches that do not go away. Got worse with second dose and then worse again with the booster. Continues to this day.
Fever 101, teeth chattering chills, body aches, bad migraine headaches, vomiting, and very sore right arm for 3 days!
flu; Initial information received on 19-Nov-2020 regarding an unsolicited valid non-serious social media case from a consumer (patient).  This case involved a patient with unknown demographics who experienced flu (Influenza), while he/she received vaccine INFLUENZA VACCINE.  Medical history, medical treatment, vaccination, concomitant medication and family history were not provided.    On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious flu (Influenza) (Unknown latency) following the administration of INFLUENZA VACCINE.  It was reported that the patient did not know about all of that, but he/she had not had the flu since he/she stopped getting the shots. And he/she only stopped once he/she found out all of the extra stuff that they put in it.  Details of laboratory data not reported.  It was not reported if the patient received a corrective treatment.  The event outcome was reported as unknown for the event, at the time of reporting.  There will be no information available on the batch number for this case.
Rash on the lower left side of the lip; Lump felt below the chin close to the throat and also below the left ear.; Lump felt below the chin close to the throat and also below the left ear.; This is a spontaneous report from a contactable consumer (patient). A 25-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: unknown) dose 1 via an unspecified route of administration in right arm on 11Feb2021, 06:45 PM (at the age of 25-year-old) as single dose for COVID-19 immunisation. Medical history and concomitant medications were none. No known allergies. No other vaccine in four weeks. No other medications in two weeks. No covid prior vaccination. On 14Feb2021 05:00 PM, the patient experienced rash on the lower left side of the lip. Lump felt below the chin close to the throat and also below the left ear. Events resulted in Doctor or other healthcare professional office/clinic visit. Received antiviral treatment for events. The patient underwent lab test post vaccination which included Q PCR, on 18Jan2021, result: Negative. The outcome of events was recovering.  Follow-up attempts completed. No further information expected.
Rash starting in lower middle back--spreading to upper back, stomach, chest , and arms.
Drug ineffective/Treatment of COVID-19; COVID-19/Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 27Dec2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 41 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "GERD" (unspecified if ongoing); "Hiatal hernia" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Penicillin, reaction(s): "Drug allergy"; Zofran, reaction(s): "Drug allergy"; Phenegran, reaction(s): "Drug allergy". The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "not recovered", described as "Drug ineffective/Treatment of COVID-19"; COVID-19 (medically significant), outcome "not recovered", described as "COVID-19/Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: testing positive beginning 2.5 days after finishing Paxlovid. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: The patient received no other medication in 2 weeks at the time of reporting. The patient was treated with Paxlovid (Batch/Lot number: GF1750) from 24Mar2023 to 28Apr2023.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300141795 same patient, different drug/events;
Received Janssen vaccine and started walking to the observation area. He started feeling lightheaded and sweaty.  After nursing intervention normalized. VSS during this event
Entire rt upper thigh swollen, red, and warm to touch, runny nose, fussy, not eating. No fever.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age. On an unknown dates, the unspecified number of patients were vaccinated with improperly stored (Oka/Merck) VARIVAX (lot# L026411, expiry date: 15-FEB-2017; lot# L015047, expiry date: 29-APR-2017; lot# L010144, expiry date: 24-MAR-2017). No adverse effects were reported. It was also reported that MMR II appears on the product list because stability questions were asked about this product but no doses of improperly stored MMR II were administered. Additional information has been requested.
Chills, violent shaking, fever (101), vomiting, diarrhea, muscle aches, anxiety.
Symptoms Started 4/28/2021 at 1010 Moderna COVID vaccine given left arm at 1005 Patient ? SOB and phlegm O2 sat 98% on RA No wheezing * Albuterol nebulizer treatment given x1 2L O2 NC O2 sat 99% No wheezing or respiratory distress Reports feeling better after treatment at 1030, O2 sat 98%RA * Encourage patient to go to ER for evaluation  Explained to the patient that she might be having an asthma flare up  She is followed by Primary care, follow up as soon as possible Her husband said he will take her to ER from our clinic, she is now stable Told patient to take her Albuterol Inhaler Q6H as needed for CP and SOB until seen by ER.
10-15min p/vax pt went limp in his moms arms but continued breathing. On return to clinic, was limp, clammy but breathing. While monitors being applied he became more alert & crying. VS remained stable over 1 hr observation period.
swelling on her right arm; half an inch long with some pink there on the surface of the skin; This is a spontaneous report from a contactable consumer. Follow-up (27May2021) received from same reporter was processed together along with initial information.   A 57-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EW0161), via an unspecified route of administration, administered in upper Arm Right on 26May2021 10:46 (at the age of 57-years-old) as 2ND DOSE, SINGLE for covid-19 immunisation. The patient medical history was none. The patient received the first dose of PFIZER-BIONTECH COVID-19 VACCINE on 05May2021 at 10:53 AM (batch/lot number: ER8733). No additional vaccines administered on same date of the Pfizer suspect. The patient did not have prior vaccinations within 4 weeks. The patient's concomitant medications were not reported. On 26May2021, the patient experienced swelling on her right arm and half an inch long with some pink color on the surface of the skin. It was reported that, the swelling on her right arm is weirdly shaped and is described as a scratch mark. The reporter said that it started just a few hours afterwards vaccination and was same by the time of the report. Reporter asked if she could put rubbing alcohol or ice on the site and asked if she had to skip any food items. The patient was not treated for the event. The event did not require a visit to emergency room and physician office. Outcome of the events was not resolved.  Follow up needed, further information has been requested.
COVID-19 - fatigue, headache, fever (4 days), chills, body aches, cough, phlegm, sneezing.
Administered Expired Vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered Expired Vaccine) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 060H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered Expired Vaccine). On 21-Jan-2022, EXPIRED PRODUCT ADMINISTERED (Administered Expired Vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient received expired vaccine from the lot that had beyond use date of 01/20/22. No side effect had been reported by patient during the 15 minute observation time. No concomitant medication were given. No treatment information were given.